CORPORATE NEWS
Untitled Page
Allergan honored for its healthy company culture and medical benefits
The Irvine-based firm receives top award from the CEO Roundtable on Cancer
BY Ashly McGlonePublished: June 08, 2010
Irvine-based health-care company Allergan earned the CEO Cancer Gold Standard, an honor given by the CEO Roundtable on Cancer, a non-profit organization founded in 2001at the request of former President George H. W. Bush. The award acknowledges the company’s ongoing efforts to reduce cancer risks among its employees.
To earn the designation, Allergan officials evaluated the firm’s health benefits and corporate culture as they relate to the five cancer-prevention actions stressed by the CEO Roundtable: discourage tobacco use, encourage physical activity, promote healthy diet and nutrition, detect cancer at its earliest stages and provide access to quality care, including participation in clinical trials.
“The leadership and commitment of Allergan and their CEO, David Pyott, is exemplary,” said William C. Weldon, CEO of Johnson & Johnson and chair of the Roundtable. “CEO Cancer Gold Standard accreditation is further testament that Allergan’s efforts to improve health begin with improving the health of their own employees.”
Founded 60 years ago as an eye care company, Allergan creates and markets pharmaceuticals, biologics and medical devices, as well as resources for research and development, manufacturing and safety surveillance. It boasts more than 8,000 employees in 100 countries.
Aliso Viejo-based Valeant Pharmaceuticals is the only other O.C.-based company to earn the CEO Cancer Gold Standard distinction.
|
||||
|
To earn the designation, Allergan officials evaluated the firm’s health benefits and corporate culture as they relate to the five cancer-prevention actions stressed by the CEO Roundtable: discourage tobacco use, encourage physical activity, promote healthy diet and nutrition, detect cancer at its earliest stages and provide access to quality care, including participation in clinical trials. “The leadership and commitment of Allergan and their CEO, David Pyott, is exemplary,” said William C. Weldon, CEO of Johnson & Johnson and chair of the Roundtable. “CEO Cancer Gold Standard accreditation is further testament that Allergan’s efforts to improve health begin with improving the health of their own employees.” Founded 60 years ago as an eye care company, Allergan creates and markets pharmaceuticals, biologics and medical devices, as well as resources for research and development, manufacturing and safety surveillance. It boasts more than 8,000 employees in 100 countries. Aliso Viejo-based Valeant Pharmaceuticals is the only other O.C.-based company to earn the CEO Cancer Gold Standard distinction. |
||||
